The BimEL tumor suppressor is a potent proapop- totic BH3-only protein. We found that, in response to survival signals, BimEL was rapidly phosphory- lated on three serine residues in a conserved degron, facilitating binding and degradation via the F box protein bTrCP. Phosphorylation of the BimEL degron was executed by Rsk1/2 and promoted by the Erk1/2-mediated phosphorylation of BimEL on Ser69. Compared to wild-type BimEL, a BimEL phos- phorylation mutant unable to bind bTrCP was stabi- lized and consequently potent at inducing apoptosis by the intrinsic mitochondrial pathway. Moreover, although non-small cell lung cancer (NSCLC) cells often become resistant to gefitinib (a clinically rele- vant tyrosine kinase inhibitor that induces apoptosis through BimEL), silencing of either bTrCP or Rsk1/2 resulted in BimEL-mediated apoptosis of both gefiti- nib-sensitive and gefitinib-insensitive NSCLC cells. Our findings reveal that bTrCP promotes cell survival in cooperation with the ERK-RSK pathway by target- ing BimEL for degradation.

βTrCP- and Rsk1/2-Mediated Degradation of BimEL Inhibits Apoptosis

Guardavaccaro, Daniele;
2009-01-01

Abstract

The BimEL tumor suppressor is a potent proapop- totic BH3-only protein. We found that, in response to survival signals, BimEL was rapidly phosphory- lated on three serine residues in a conserved degron, facilitating binding and degradation via the F box protein bTrCP. Phosphorylation of the BimEL degron was executed by Rsk1/2 and promoted by the Erk1/2-mediated phosphorylation of BimEL on Ser69. Compared to wild-type BimEL, a BimEL phos- phorylation mutant unable to bind bTrCP was stabi- lized and consequently potent at inducing apoptosis by the intrinsic mitochondrial pathway. Moreover, although non-small cell lung cancer (NSCLC) cells often become resistant to gefitinib (a clinically rele- vant tyrosine kinase inhibitor that induces apoptosis through BimEL), silencing of either bTrCP or Rsk1/2 resulted in BimEL-mediated apoptosis of both gefiti- nib-sensitive and gefitinib-insensitive NSCLC cells. Our findings reveal that bTrCP promotes cell survival in cooperation with the ERK-RSK pathway by target- ing BimEL for degradation.
2009
ubiquitin, apoptosis ligase
File in questo prodotto:
File Dimensione Formato  
Dehan Mol Cell 2009.pdf

accesso aperto

Licenza: Dominio pubblico
Dimensione 855.17 kB
Formato Adobe PDF
855.17 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/992842
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 148
  • ???jsp.display-item.citation.isi??? 151
social impact